Back
Lineage Cell Therapeutics Stock Price Chart
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
55
LCTX
Lineage Cell Therapeutics
Last Price:
$0.91
Seasonality Move:
-0.75%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Lineage Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.79 | Buy |
| 20-day SMA: | 0.69 | Buy |
| 50-day SMA: | 0.55 | Buy |
| 200-day SMA: | 0.66 | Buy |
| 8-day EMA: | 0.81 | Buy |
| 20-day EMA: | 0.71 | Buy |
| 50-day EMA: | 0.61 | Buy |
| 200-day EMA: | 0.67 | Buy |
Lineage Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 80.12 | Buy |
| Chaikin Money Flow: | 2851249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.78) | Buy |
| Bollinger Bands (100): | (0.44 - 0.68) | Buy |
Lineage Cell Therapeutics Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lineage Cell Therapeutics Stock
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 0.92 while LCTX 8-day simple moving average is 0.79, which is a Buy signal.
-
The stock price of LCTX is 0.92 while Lineage Cell Therapeutics 20-day SMA is 0.69, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day simple moving average is 0.55 while LCTX share price is 0.92, making it a Buy technically.
-
LCTX stock price is 0.92 and Lineage Cell Therapeutics 200-day simple moving average is 0.66, creating a Buy signal.
LCTX Technical Analysis vs Fundamental Analysis
Buy
55
Lineage Cell Therapeutics (LCTX)
is a Buy
Is Lineage Cell Therapeutics a Buy or a Sell?
-
Lineage Cell Therapeutics stock is rated a BuyThe current Lineage Cell Therapeutics [LCTX] share price is $0.92. The Score for LCTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Lineage Cell Therapeutics Stock Info
Market Cap:
209M
Price in USD:
0.92
Share Volume:
4M
Lineage Cell Therapeutics 52-Week Range
52-Week High:
1.15
52-Week Low:
0.37
Buy
55
Lineage Cell Therapeutics (LCTX)
is a Buy
Lineage Cell Therapeutics Share Price Forecast
-
What is the Lineage Cell Therapeutics stock price today?The Lineage Cell Therapeutics stock price is 0.92 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics is not overvalued.
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 0.92 while LCTX 8-day exponential moving average is 0.81, which is a Buy signal.
-
The stock price of LCTX is 0.92 while Lineage Cell Therapeutics 20-day EMA is 0.71, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day exponential moving average is 0.61 while LCTX share price is 0.92, making it a Buy technically.
-
LCTX stock price is 0.92 and Lineage Cell Therapeutics 200-day simple moving average is 0.67, creating a Buy signal.
Fundamental Analysis of Lineage Cell Therapeutics
Is Lineage Cell Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.
Technical Analysis of Lineage Cell Therapeutics
Should I short Lineage Cell Therapeutics stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Lineage Cell Therapeutics is a Buy
-
Lineage Cell Therapeutics Relative Strength Index (RSI) is 80.12, which suggest Lineage Cell Therapeutics is overbought
-
The Bollinger Bands (25) for Lineage Cell Therapeutics is (0.52 - 0.78), which suggest Lineage Cell Therapeutics is a Buy
-
The Bollinger Bands (100) for Lineage Cell Therapeutics is (0.44 - 0.68), which suggest Lineage Cell Therapeutics is a Buy
* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.